75231-1 |
Nefazodone |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Nefazodone [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
75231-1 |
|
|
|
|
Both |
|
|
|
0 |
Nefazodone Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Nefadar; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serzone; UA; UR; Urn |
2.73 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
75232-9 |
Norcitalopram |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Norcitalopram [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
75232-9 |
|
|
|
|
Both |
|
|
|
0 |
Norcitalopram Ur Ql |
|
|
|
|
|
Citalopram metabolite; Desmeth; Desmethylcitalopram; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
75233-7 |
Norsertraline |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Norsertraline [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
75233-7 |
|
|
|
|
Both |
|
|
|
0 |
Norsertraline Ur Ql |
|
|
|
|
|
Desmeth; Desmethylsertraline; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sertraline metabolite; Setralinemetab; UA; UR; Urn |
2.73 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
75234-5 |
O-desmethylvenlafaxine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
O-desmethylvenlafaxine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
75234-5 |
|
|
|
|
Both |
|
|
|
0 |
ODV Ur Ql |
|
|
|
|
|
Desmeth; Desvenlafaxine; DRUG/TOXICOLOGY; Drugs; Norvenlafaxin; Norvenlafaxine; O-desmethylvenlafaxine; ODV; Ordinal; Point in time; PR; Pristiq; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Venlafaxine metabolite |
2.73 |
2.48 |
|
|
|
|
|
|
|
|
|
|
Release 2.69: COMPONENT: Resolve ambiguity in name norvenlafaxine, which has O-desmethyl and N-desmethyl forms, O-desmethyl reported to be the one measured in assays.; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
75235-2 |
Vilazodone |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Vilazodone [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
75235-2 |
|
|
|
|
Both |
|
|
|
0 |
Vilaz Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Viibryd |
2.73 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
75236-0 |
Crystals |
Naric |
Body fld |
Pt |
Qn |
Microscopy.light |
|
ACTIVE |
Crystals [#/area] in Body fluid by Light microscopy |
|
MIN |
DefinitionDescription |
|
|
/LPF |
|
|
|
|
|
|
HEM/BC |
|
75236-0 |
|
Microscopy.light |
|
|
Both |
|
|
|
0 |
Crystals #/area Fld Micro |
|
|
|
|
|
#/area; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Crys; Cryst; Crystal; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.48 |
2.48 |
|
|
|
|
|
|
|
/[LPF] |
|
|
|
0 |
75237-8 |
Erythrocytes |
Naric |
Synv fld |
Pt |
Qn |
Microscopy.light.HPF |
|
ACTIVE |
Erythrocytes [#/area] in Synovial fluid by Microscopy high power field |
|
MIN |
DefinitionDescription |
|
|
/HPF |
|
|
|
|
|
|
HEM/BC |
|
75237-8 |
|
Microscopy.light.HPF |
|
|
Both |
|
|
|
0 |
RBC #/area Snv HPF |
|
|
|
|
|
#/area; Discocytes; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; LM; Micro; Micros; Microscopic; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; SF; SNV; Syn; Syn fl; Synov; Synovial fluid |
2.48 |
2.48 |
|
|
|
|
|
|
|
/[HPF] |
|
|
|
0 |
75238-6 |
Procedure note |
Find |
{Setting} |
Pt |
Doc |
Interventional radiology |
|
ACTIVE |
Interventional radiology procedure note |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
75238-6 |
|
Interventional radiology |
|
|
Both |
|
|
|
0 |
IR Procedure note |
|
|
|
|
|
DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; IR; notes; Point in time; Random; Visit note |
2.63 |
2.48 |
|
|
|
|
|
|
|
|
|
|
|
0 |
75239-4 |
Albumin.ischemia modified |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Albumin.ischemia modified [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
CHEM |
|
75239-4 |
|
|
|
|
Both |
|
|
|
0 |
IMA Ser-aCnc |
|
|
|
|
|
Alb; Arbitrary concentration; Chemistry; IMA; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.68 |
2.48 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
7524-2 |
Prunus persica var nucipersica Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Nectarine IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
7524-2 |
|
|
|
|
Both |
|
|
|
0 |
Nectarine IgG Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f095; f162; f95; Immune globulin G; Immunoglobulin G; Nectarine; Peach; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
1.0h(2) |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
75240-2 |
Meat fibers |
Naric |
Stool |
Pt |
Qn |
Microscopy.light.LPF |
|
ACTIVE |
Meat fibers [#/area] in Stool by Microscopy low power field |
|
MIN |
DefinitionDescription |
|
|
/LPF |
|
|
|
|
|
|
CHEM |
|
75240-2 |
|
Microscopy.light.LPF |
|
|
Both |
|
|
|
0 |
Meat Fibers #/area Stl LPF |
|
|
|
|
|
#/area; Bowel movement; Chemistry; creatorrhea; Faecal; Faeces; Fecal; Feces; Fiber; LM; Micro; Micros; Microscopic; Muscle fiber; Muscle fibers; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal |
2.48 |
2.48 |
|
|
|
|
|
|
|
/[LPF] |
|
|
|
0 |
75241-0 |
Procalcitonin |
MCnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Procalcitonin [Mass/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHEM |
|
75241-0 |
|
IA |
|
|
Both |
|
|
|
0 |
Procalcitonin SerPl IA-mCnc |
|
|
|
|
|
Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; PCT; Pl; Plasma; Plsm; Point in time; proCT; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.73 |
2.48 |
|
|
|
|
|
|
|
ng/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
75242-8 |
Antipsychotics |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Antipsychotics [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
75242-8 |
|
Screen |
|
|
Both |
|
|
|
0 |
Antipsychotics Ur Ql Scn |
|
|
|
|
|
Antipsychotic; DRUG/TOXICOLOGY; Drugs; neuroleptics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.56 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
75243-6 |
Norton scale panel |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
Norton scale panel |
|
MIN |
DefinitionDescription |
|
|
|
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
|
|
PANEL.SURVEY.NORTON |
|
75243-6 |
|
|
|
|
Order |
|
|
|
0 |
|
|
|
|
|
|
Norton Scale Pnl; Pan; PANEL.SURVEY.NORTON; Panl; Pnl; Point in time; Random; Survey; SURVEY.NORTON |
2.5 |
2.48 |
|
Panel |
|
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
|
|
|
|
0 |
75244-4 |
Physical condition |
Find |
^Patient |
Pt |
Ord |
Observed.Norton scale |
|
ACTIVE |
Physical condition [Norton scale] |
|
MIN |
DefinitionDescription |
|
|
|
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
|
|
SURVEY.NORTON |
|
75244-4 |
|
Observed.Norton scale |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NORTON |
2.5 |
2.48 |
|
|
|
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
|
|
|
|
0 |
75245-1 |
Mental condition |
Find |
^Patient |
Pt |
Ord |
Observed.Norton scale |
|
ACTIVE |
Mental condition [Norton scale] |
|
MIN |
DefinitionDescription |
|
|
|
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
|
|
SURVEY.NORTON |
|
75245-1 |
|
Observed.Norton scale |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NORTON |
2.5 |
2.48 |
|
|
|
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
|
|
|
|
0 |
75246-9 |
Activity |
Find |
^Patient |
Pt |
Ord |
Observed.Norton scale |
|
ACTIVE |
Activity [Norton scale] |
|
MIN |
DefinitionDescription |
|
|
|
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
|
|
SURVEY.NORTON |
|
75246-9 |
|
Observed.Norton scale |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Activ; Actvty; Finding; Findings; Movements; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NORTON |
2.5 |
2.48 |
|
|
|
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
|
|
|
|
0 |
75247-7 |
Mobility |
Find |
^Patient |
Pt |
Ord |
Observed.Norton scale |
|
ACTIVE |
Mobility [Norton scale] |
|
MIN |
DefinitionDescription |
|
|
|
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
|
|
SURVEY.NORTON |
|
75247-7 |
|
Observed.Norton scale |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NORTON |
2.5 |
2.48 |
|
|
|
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
|
|
|
|
0 |
75248-5 |
Incontinence |
Find |
^Patient |
Pt |
Ord |
Observed.Norton scale |
|
ACTIVE |
Incontinence [Norton scale] |
|
MIN |
DefinitionDescription |
|
|
|
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
|
|
SURVEY.NORTON |
|
75248-5 |
|
Observed.Norton scale |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NORTON |
2.5 |
2.48 |
|
|
|
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
|
|
|
|
0 |
75249-3 |
Norton scale score.total |
Score |
^Patient |
Pt |
Qn |
Observed.Norton scale |
|
ACTIVE |
Norton scale total score |
|
MIN |
DefinitionDescription |
|
|
score |
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
|
|
SURVEY.NORTON |
|
75249-3 |
|
Observed.Norton scale |
|
|
Both |
|
|
|
0 |
|
|
|
|
|
|
Norton Scale Total Score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.NORTON; Tot; Totl |
2.5 |
2.48 |
|
|
|
|
Copyright �© 1962 Centre for Policy on Ageing (formerly NCCOP), London, UK. Reproduced with permission. |
|
|
{score} |
|
|
We made an administrative decision to define the total scores from various survey instruments as Quantitative rather than ordinal. There is no intention to change the existing meaning. |
0 |
7525-9 |
Nigrospora oryzae Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Nigrospora oryzae IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
7525-9 |
|
|
|
|
Both |
|
|
|
0 |
N orzae IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Khuskia oryzae; m68; N orzae; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
75250-1 |
Are you deaf or do you have difficulty hearing |
Find |
^Patient |
Pt |
Ord |
HHS.ACA Section 4302.ONC |
|
TRIAL |
Are you deaf or do you have difficulty hearing [HHS.ACA Section 4302.ONC] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.HHS |
|
75250-1 |
|
HHS.ACA Section 4302.ONC |
|
|
Observation |
|
|
|
0 |
|
|
|
Are you deaf or do you have difficulty hearing? |
|
|
Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); Finding; Findings; HHS.ACASec4302; HHS.ACASec4302.ONC; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.HHS |
2.48 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
75251-9 |
Are you blind or do you have difficulty seeing |
Find |
^Patient |
Pt |
Ord |
HHS.ACA Section 4302.ONC |
|
TRIAL |
Are you blind or do you have difficulty seeing [HHS.ACA Section 4302.ONC] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.HHS |
|
75251-9 |
|
HHS.ACA Section 4302.ONC |
|
|
Observation |
|
|
|
0 |
|
|
|
Are you blind or do you have difficulty seeing? |
|
|
Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); Finding; Findings; HHS.ACASec4302; HHS.ACASec4302.ONC; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.HHS |
2.48 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
75252-7 |
Do you have difficulty walking or climbing stairs |
Find |
^Patient |
Pt |
Ord |
HHS.ACA Section 4302.ONC |
|
TRIAL |
Do you have difficulty walking or climbing stairs [HHS.ACA Section 4302.ONC] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.HHS |
|
75252-7 |
|
HHS.ACA Section 4302.ONC |
|
|
Observation |
|
|
|
0 |
|
|
|
Do you have difficulty walking or climbing stairs? |
|
|
Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); Finding; Findings; HHS.ACASec4302; HHS.ACASec4302.ONC; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.HHS |
2.48 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
75253-5 |
Because of a physical, mental, or emotional condition, do you have difficulty doing errands such as visiting a doctor's office or shopping |
Find |
^Patient |
Pt |
Ord |
HHS.ACA Section 4302.ONC |
|
TRIAL |
Because of a physical, mental, or emotional condition, do you have difficulty doing errands such as visiting a doctor's office or shopping [HHS.ACA Section 4302.ONC] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.HHS |
|
75253-5 |
|
HHS.ACA Section 4302.ONC |
|
|
Observation |
|
|
|
0 |
|
|
|
Because of a physical, mental, or emotional condition, do you have difficulty doing errands such as visiting a doctor's office or shopping? |
|
|
Arterial Stenosis; Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); Finding; Findings; HHS.ACASec4302; HHS.ACASec4302.ONC; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.HHS |
2.48 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |